Rchr
J-GLOBAL ID：200901003151397821   Update date: Apr. 18, 2024

Takiguchi Yuichi

タキグチ ユウイチ | Takiguchi Yuichi
Affiliation and department：
Chiba University Department of Medical Oncology, Graduate School of Medicine

About Chiba University Department of Medical Oncology, Graduate School of Medicine


Job title： Professor
Homepage URL  (1)： http://www.m.chiba-u.ac.jp/class/respir/index.html
Research field  (2)： Hematology and oncology ,  Respiratory medicine
Research keywords  (1)： Medical Oncology
Research theme for competitive and other funds  (29)：
  • 2020 - 2024 Development of molecular targeted therapy for pulmonary squamous cell carcinoma
  • 2017 - 2020 Epithelial-mesenchymal transition targeted therapy for malignant pleural mesothelioma
  • 2014 - 2018 Development of targeted therapy to overcome drug resistance in malignant mesothelioma
  • 2014 - 2017 Restoration of chemoresistance by modifying epithelial-to-mesenchymal transition.
  • 2014 - 2016 The exploration of the Hedgehog pathway as a treatment target in neuroendocrine carcinoma of the lung.
Show all
Papers (334)：
  • Aika Tanzawa, Kengo Saito, Masayuki Ota, Koji Takahashi, Izumi Ohno, Toyoyuki Hanazawa, Katsuhiro Uzawa, Yuichi Takiguchi. Salivary gland-type cancers: cross-organ demographics of a rare cancer. International journal of clinical oncology. 2024
  • Satoshi Ikeda, Takashi Ogura, Terufumi Kato, Hirotsugu Kenmotsu, Yoko Agemi, Takaaki Tokito, Kentaro Ito, Kohsuke Isomoto, Yuichi Takiguchi, Yasuto Yoneshima, et al. Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis. Annals of the American Thoracic Society. 2024
  • Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi, Tetsuro Kondo, Shuji Murakami, Yoshimasa Shiraishi, Hisao Imai, Daijiro Harada, Kazutoshi Isobe, Hidetoshi Itani, et al. Phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non-small-cell lung cancer: TORG1937 (DATE study). Clinical cancer research : an official journal of the American Association for Cancer Research. 2024
  • Shinji Nakamichi, Kaoru Kubota, Kotone Matsuyama, Toshihiro Misumi, Toshiyuki Kozuki, Shunichi Sugawara, Katsuhiko Naoki, Nobuaki Kobayashi, Takehito Shukuya, Tsuneo Shimokawa, et al. A Phase II Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung Cancer: TORG2241 (UBE-Q). Clinical lung cancer. 2024. 25. 1. 85-90
  • 大野 泉, 西村 基, 大内 麻愉, 菅 元泰, 永嶌 裕樹, 高橋 幸治, 大山 広, 平野 翔, 中島 裟文, 鬼澤 歩, et al. 当院膵癌患者におけるがん遺伝子パネル検査の現状と課題. 日本消化器病学会雑誌. 2023. 120. 臨増大会. A842-A842
ｍore...
MISC (426)：
  • 大野泉, 大野泉, 大野泉, 西村基, 西村基, 大内麻愉, 菅元泰, 菅元泰, 永嶌裕樹, 高橋幸治, et al. 当院膵癌患者におけるがん遺伝子パネル検査の現状と課題. 日本消化器病学会雑誌(Web). 2023. 120
  • TANIGUCHI Yuri, SHIMOKAWA Tsuneo, TAKIGUCHI Yuichi, MISUMI Toshihiro, NAKAMURA Yukiko, KAWASHIMA Yosuke, FURUYA Naoki, SHIRAISHI Yoshimasa, HARADA Toshiyuki, TANAKA Hisashi, et al. A randomized Phase II/III trial of nivolumab vs nivolumab+ docetaxel for previously-treated ICI-naive advanced NSCLC: TORG1630 final report. 日本呼吸器学会誌(Web). 2023. 12
  • FURUYA Naoki, TANIGUCHI Yuri, SHIMOKAWA Tsuneo, TAKIGUCHI Yuichi, MISUMI Toshihiro, INOUE Takeo, KAWASHIMA Yosuke, YONESHIMA Yasuto, HARADA Toshiyuki, TANAKA Hisashi, et al. Randomized P-II/III trial of nivolumab (NIV) vs NIV+docetaxel for previously treated advanced/recurrent NSCLC: TORG1630. 日本臨床腫瘍学会学術集会(CD-ROM). 2023. 20th
  • YAMAZAKI Koji, KENMOTSU Hirotsugu, YAMAMOTO Nobuyuki, MISUMI Toshihiro, YOH Kiyotaka, TAKAHASHI Toshiaki, SAITO Haruhiro, SUGAWARA Shunichi, NAKAGAWA Kazuhiko, SUGIO Kenji, et al. Final results of phase III study of pemetrexed/cisplatin vs. vinorelbine/cisplatin for resected non-squamous NSCLC. 日本臨床腫瘍学会学術集会(CD-ROM). 2023. 20th
  • SAITO Go, TOKITO Takaaki, ISHII Hidenobu, TAKIGUCHI Yuichi, MINATO Koichi, IMAI Hisao, IMAI Hisao, TANAKA Hiroshi, MIURA Satoru, WATANABE Kageaki, et al. A phase II study of chemotherapy plus local therapy for non-small cell lung cancer with oligometastases: TORG1529. 日本臨床腫瘍学会学術集会(CD-ROM). 2023. 20th
ｍore...
Works (6)：
  • 公害認定患者を対象とした、車載型らせんCTによる胸部精密検診
    1997 - 1999
  • Mass screening for lung cancer by means of mobile spiral CT scaner, in an air-polluted area.
    1997 - 1999
  • がんの告知,臨床試験,終末期医療等に対する意識調査
    1998 -
  • Mass screening of Lung cancer by means of mobile spiral CT scaner, and its system development.
    1998 -
  • A poll on informed consent, clinical trial, and terminal care for patients with cancer.
    1998 -
ｍore...
Education (1)：
  • 1977 - 1983 Chiba University School of Medicine
Professional career (1)：
  • M.D. & Ph.D
Work history (1)：
  • 1992/10 - 1995/03 Los Alamos National Laboratory Life Science Division Postdoctoral fellow
Committee career (13)：
  • 2015 - 現在 日本呼吸器内視鏡学会 理事
  • 2012 - 現在 日本肺癌学会 常任理事
  • 2010 - 現在 日本肺癌学会 理事
  • 2008 - 現在 日本臨床腫瘍学会 協議員
  • 2003 - 現在 日本呼吸器内視鏡学会 評議員
Show all
Association Membership(s) (18)：
日本CT検診学会 ,  International Association for Study of Lung Cancer (IASLC) ,  European Society of Medical Oncology(ESMO) ,  American association for Cancer Research (AACR) ,  American Society of Clinical Oncology (ASCO) ,  日本癌治療学会 ,  Japan Society for Medical Oncology ,  日本呼吸リハビリテーション学会 ,  American College of Chest Physician (ACCP) ,  Japanese Cancer Association ,  Japanese Society of Lung Cancer ,  Japanese Society of Internal Medicine ,  Japanese Respiratory Society ,  日本結核・非結核性抗酸菌症学会 ,  Japan Society for Respiratory Endoscopy ,  Chiba Medical Society ,  Asia Pacific Society for Respirology (APSR) ,  American Thoracic Society (ATS)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM